Advisornet Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

Advisornet Financial’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-400	Closed	-$1K	–	2084
2019 Q3	$1K	Hold	400	–	–	﹤0.01%	1829
2019 Q2	$1K	Hold	400	–	–	﹤0.01%	1672
2019 Q1	$1K	Hold	400	–	–	﹤0.01%	1567
2018 Q4	$1K	Hold	400	–	–	﹤0.01%	1452
2018 Q3	$1K	Hold	400	–	–	﹤0.01%	1448
2018 Q2	$1K	Hold	400	–	–	﹤0.01%	1558
2018 Q1	$1K	Buy	+400	New	+$1.09K	﹤0.01%	1395

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Advisornet Financial's PDLI Position: Q4 2019 in Review

Advisornet Financial sold out of PDL BioPharma, Inc. (PDLI) in Q4 2019, closing a stake of 400 shares — an estimated $1K sold.

Advisornet Financial first reported a position in PDLI in Q1 2018 and held it in 7 quarters. The position peaked at $1K in Q3 2019. 150 funds tracked by Wall St. Rank hold PDLI as of Q4 2019.

Advisornet Financial reported no remaining PDL BioPharma, Inc. position as of Q4 2019 after selling out during the quarter.
Advisornet Financial sold 400 PDL BioPharma, Inc. shares in Q4 2019, an estimated $1K.
Advisornet Financial first reported a position in PDL BioPharma, Inc. in Q1 2018 and held it in 7 quarters.
Advisornet Financial's PDL BioPharma, Inc. position peaked at $1K in Q3 2019.
150 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2019.

Based on Advisornet Financial's 13F filing for Q4 2019, filed 12 Feb 2020.